Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission: A Safety Trial in Kidney Transplant Recipients

NCT07488481 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07488481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07488481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission: A Safety Trial in Kidney Transplant Recipients
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 16, 2026
Completion date
December 31, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus (cmv) infection, kidney transplant recipient